ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 1672
Read the official notice at FDA (drug) →
Get alerts for Accord Healthcare
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- ACCORD HEALTHCARE, INC.
- Product
- Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
- Reason / hazard
- Subpotent Drug
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide within the United States
- Recall initiated
- 2026-08-06
- Code info
- a) Lot # D2402430, D2402431, Exp Date: 10/31/2026. b) Lot #: D2402432, Exp. Date 10/31/2026; D2500180, Exp. Date 12/31/2026.
- Product quantity
- N/A
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Raleigh
- State
- NC
- Country
- United States
- Event id
- 99584
Free daily digest + "My products" watchlist